Fri Sep 20 07:38:57 UTC 2024: ## Beximco Pharmaceuticals Stock Dips Below Key Moving Average
**London, UK – September 20, 2024** – Shares of Beximco Pharmaceuticals Limited (LON:BXP) experienced a downturn on Thursday, falling below its crucial 200-day moving average. The stock closed at GBX 22 ($0.29), down from its 200-day moving average of GBX 36.29 ($0.48). This decline was accompanied by a significant trading volume of 2,374,320 shares.
The company, which manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh, has a market capitalization of £95.91 million. Beximco Pharmaceuticals offers a wide range of products, including treatments for allergies, pain, infections, cardiovascular issues, and more. The company also provides contract manufacturing services to other companies.
Despite the recent decline, Beximco Pharmaceuticals’ financial ratios suggest a stable position. The company boasts a debt-to-equity ratio of 14.73, a current ratio of 1.80, and a quick ratio of 0.37.
**Stay updated on Beximco Pharmaceuticals and related companies with MarketBeat.com’s FREE daily email newsletter.**
**Note:** This news article is based on the provided text and does not include any additional research or opinions.
First Piper 